Catabasis Pharmaceuticals, Inc. CATB
8.54 +8.54
Day range unavailable
52-week range unavailable
Revenue & Expenses
No quarterly statement lines
CATB has no quarterly lines for this statement.
Day range unavailable
52-week range unavailable
No quarterly statement lines
CATB has no quarterly lines for this statement.